Pathological Fracture of the Tibia As a First Sign Of
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
A Rare Cause of Lytic Lesion: the Brown Tumors
MOJ Orthopedics & Rheumatology Case Report Open Access A rare cause of lytic lesion: the brown tumors Abstract Volume 11 Issue 6 - 2019 Introduction: Brown tumor is a tumor-like lesion that represents the terminal stage of the bone remodeling process in prolonged hyperparathyroidism and has an overall incidence of Maroua Khaloui, Fatma Daoud, Imène Rachdi, 3%. It may not be distinguishable from other osteolytic lesions of malignancy. We illustrate Mehdi Somai, Hana Zoubeidi, Zohra Aydi, a case of primary hyperparathyroidism with brown tumour which was initially mistaken for Nedia Hammami, Wided Hizem, Besma Ben malignant disease. Dhaou, Fatma Boussema Department of Internal medicine, Habib Thameur Hospital, Tunis Case report: A 64-year-old female patient with a medical history of dyslipidemia repeated El Manar University, Tunisia acute pancreatitis and retrobulbar neuritis was referred to our department for evaluation of hypercalcemia. The association with a hypogammaglobulinemia gave rise to the initial Correspondence: Imène Rachdi, Department of Internal diagnosis of humoral hypercalcemia of multiple myeloma. The radiological evaluation medicine, Habib Thameur Hospital, Tunis El Manar University, Ali of the skeleton showed an isolated lytic lesion on the humerus. No electrophoretic signs Ben Ayed Street, 1089 Tunis, Tunisia, of monoclonal secretion in the blood or urine were found. Nevertheless, laboratory Email investigations revealed a constellation of primary hyperparathyroidism. Computed tomography localized a right parathyroid adenoma, which was surgically removed. Also, Received: October 25, 2019 | Published: November 15, 2019 we concluded that the humeral lesion was in fact a Brown tumor. Conclusion: This case reinforces the need to consider brown tumor of hyperparathyroidism in the differential diagnosis of an osteolytic lesion with hypercalcemia. -
Advances in the Pathogenesis and Possible Treatments for Multiple Hereditary Exostoses from the 2016 International MHE Conference
Connective Tissue Research ISSN: 0300-8207 (Print) 1607-8438 (Online) Journal homepage: https://www.tandfonline.com/loi/icts20 Advances in the pathogenesis and possible treatments for multiple hereditary exostoses from the 2016 international MHE conference Anne Q. Phan, Maurizio Pacifici & Jeffrey D. Esko To cite this article: Anne Q. Phan, Maurizio Pacifici & Jeffrey D. Esko (2018) Advances in the pathogenesis and possible treatments for multiple hereditary exostoses from the 2016 international MHE conference, Connective Tissue Research, 59:1, 85-98, DOI: 10.1080/03008207.2017.1394295 To link to this article: https://doi.org/10.1080/03008207.2017.1394295 Published online: 03 Nov 2017. Submit your article to this journal Article views: 323 View related articles View Crossmark data Citing articles: 1 View citing articles Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=icts20 CONNECTIVE TISSUE RESEARCH 2018, VOL. 59, NO. 1, 85–98 https://doi.org/10.1080/03008207.2017.1394295 PROCEEDINGS Advances in the pathogenesis and possible treatments for multiple hereditary exostoses from the 2016 international MHE conference Anne Q. Phana, Maurizio Pacificib, and Jeffrey D. Eskoa aDepartment of Cellular and Molecular Medicine, Glycobiology Research and Training Center, University of California, San Diego, La Jolla, CA, USA; bTranslational Research Program in Pediatric Orthopaedics, Division of Orthopaedic Surgery, The Children’s Hospital of Philadelphia, Philadelphia, PA, USA ABSTRACT KEYWORDS Multiple hereditary exostoses (MHE) is an autosomal dominant disorder that affects about 1 in 50,000 Multiple hereditary children worldwide. MHE, also known as hereditary multiple exostoses (HME) or multiple osteochon- exostoses; multiple dromas (MO), is characterized by cartilage-capped outgrowths called osteochondromas that develop osteochondromas; EXT1; adjacent to the growth plates of skeletal elements in young patients. -
Post-Traumatic Osteolysis of the Clavicle: a Case Report C
Arch Emerg Med: first published as 10.1136/emj.3.2.129 on 1 June 1986. Downloaded from Archives of Emergency Medicine, 1986, 3, 129-132 Post-traumatic osteolysis of the clavicle: a case report C. J. GRIFFITHS AND E. GLUCKSMAN Department ofAccident and Emergency Medicine, King's College Hospital, Denmark Hill, London, England SUMMARY A case of post-traumatic osteolysis of the clavicle occurring in a 25-year-old male is described. The condition should be suspected in anyone giving a history of persistent shoulder pain following trauma or intensive sporting activities. Characteristic resorp- tion of the distal tip of the clavicle is found on X-ray. The condition usually responds by copyright. within 2 years to conservative treatment. Previous reports ofthe condition are reviewed, and the possible pathogenesis and differential diagnosis discussed. INTRODUCTION Post-traumatic osteolysis of the clavicle is an uncommon condition characterized by http://emj.bmj.com/ persistent shoulder pain associated with decalcification of the distal tip of the clavicle following trauma to the acromio-clavicular joint (Madsen, 1963; Smart, 1972; Quinn & Glass, 1983). Patients usually give a history of previous trauma to the shoulder, but the condition may follow active sports such as weight training (Cahill, 1982) or the use of pneumatic tools (Ehricht, 1959). The condition usually resolves within 2 years in the absence of further trauma. This article describes a case of post-traumatic osteolysis of on September 28, 2021 by guest. Protected the clavicle, and discusses the diagnosis and possible pathogenesis of the condition. CASE REPORT A 25-year-old medical student (C.G.) was involved in a bicycle accident and received a direct blow to his right shoulder. -
Jaw Tumor: an Uncommon Presenting Manifestation of Primary Hyperparathyroidism Jaw Tumor: an Uncommon Presenting Manifestation of Primary Hyperparathyroidism
WJOES CASE REPORT Jaw Tumor: An Uncommon Presenting Manifestation of Primary Hyperparathyroidism Jaw Tumor: An Uncommon Presenting Manifestation of Primary Hyperparathyroidism 1Roy Phitayakorn, 2Christopher R McHenry 1Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 2Department of Surgery, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH Correspondence: Roy Phitayakorn, Department of Surgery, Massachusetts General Hospital, WACC 460 E, 15 Parkman Street, Boston, MA 02114, USA, Phone: (617) 643-0544, Fax: (617) 724-2574, e-mail: [email protected] ABSTRACT Introduction: To report two unusual cases of primary hyperparathyroidism (HPT) that initially manifested with a “ jaw tumor” and to discuss the clinical implications of a giant cell granuloma vs an ossifying fibroma of the jaw. Material and methods: The history, physical examination, laboratory values and the imaging and pathologic findings are described in two patients who presented with a “jaw tumor” and were subsequently diagnosed with primary HPT. The diagnosis and management of osteitis fibrosa cystica and HPT-jaw tumor syndrome are reviewed. Results: Patient #1 was a 70-year-old male who presented with hypercalcemia, severe jaw pain, and an enlarging mass in his mandible. Biopsy of the mass revealed a giant cell tumor and he was subsequently diagnosed with primary HPT. A sestamibi scan demonstrated a single focus of abnormal radiotracer accumulation, corresponding to a 13,470 mg parathyroid adenoma, which was resected. Postoperatively, the serum calcium normalized and the giant cell granuloma regressed spontaneously. Patient #2 was a 36-year-old male with four incidentally discovered tumors of the mandible and maxilla, who was diagnosed with normocalcemic HPT and vitamin D deficiency. -
Metabolic Bone Disease 5
g Metabolic Bone Disease 5 Introduction, 272 History and examination, 275 Osteoporosis, 283 STRUCTURE AND FUNCTION, 272 Investigation, 276 Paget’s disease of bone, 288 Structure of bone, 272 Management, 279 Hyperparathyroidism, 290 Function of bone, 272 DISEASES AND THEIR MANAGEMENT, 280 Hypercalcaemia of malignancy, 293 APPROACH TO THE PATIENT, 275 Rickets and osteomalacia, 280 Hypocalcaemia, 295 Introduction Calcium- and phosphate-containing crystals: set in a structure• similar to hydroxyapatite and deposited in holes Metabolic bone diseases are a heterogeneous group of between adjacent collagen fibrils, which provide rigidity. disorders characterized by abnormalities in calcium At least 11 non-collagenous matrix proteins (e.g. osteo- metabolism and/or bone cell physiology. They lead to an calcin,• osteonectin): these form the ground substance altered serum calcium concentration and/or skeletal fail- and include glycoproteins and proteoglycans. Their exact ure. The most common type of metabolic bone disease in function is not yet defined, but they are thought to be developed countries is osteoporosis. Because osteoporosis involved in calcification. is essentially a disease of the elderly, the prevalence of this condition is increasing as the average age of people Cellular constituents in developed countries rises. Osteoporotic fractures may lead to loss of independence in the elderly and is imposing Mesenchymal-derived osteoblast lineage: consist of an ever-increasing social and economic burden on society. osteoblasts,• osteocytes and bone-lining cells. Osteoblasts Other pathological processes that affect the skeleton, some synthesize organic matrix in the production of new bone. of which are also relatively common, are summarized in Osteoclasts: derived from haemopoietic precursors, Table 3.20 (see Chapter 4). -
A Case of Osteitis Fibrosa Cystica (Osteomalacia?) with Evidence of Hyperactivity of the Para-Thyroid Bodies
A CASE OF OSTEITIS FIBROSA CYSTICA (OSTEOMALACIA?) WITH EVIDENCE OF HYPERACTIVITY OF THE PARA-THYROID BODIES. METABOLIC STUDY II Walter Bauer, … , Fuller Albright, Joseph C. Aub J Clin Invest. 1930;8(2):229-248. https://doi.org/10.1172/JCI100262. Research Article Find the latest version: https://jci.me/100262/pdf A CASE OF OSTEITIS FIBROSA CYSTICA (OSTEOMALACIA?) WITH EVIDENCE OF HYPERACTIVITY OF THE PARA- THYROID BODIES. METABOLIC STUDY IIF By WALTER BAUER,2 FULLER ALBRIGHT3 AND JOSEPH C. AUB (From the Medical Clinic of the Massachutsetts General Hospital, Boston) (Received for publication February 5, 1929) INTRODUCTION In a previous paper (1) we have pointed out certain characteristic responses in the calcium and phosphorus metabolisms resulting from parathormone4 administration to essentially normal individuals. In the present paper, similar studies will be reported on a patient who presented a condition suggestive of idiopathic hyperparathyroidism. CASE HISTORY The patient, Mr. C. M., sea captain, aged 30, was transferred from the Bellevue Hospital Service to the Special Study Ward of the Massachusetts General Hospital through the courtesy of Dr. Eugene F. DuBois, for further investigation of his calcium metabolism and for consideration of parathyroidectomy. His complete case history has been reported by Hannon, Shorr, McClellan and DuBois (2). It describes a man invalided for over three years with symptoms resulting from a generalized skeletal decalcification. (See x-rays, figs. 1 to 4.) 1 This is No. VII of the series entitled "Studies of Calcium and Phosphorus Metabolism" from the Medical Clinic of the Massachusetts General Hospital. 2 Resident Physician, Massachusetts General Hospital. ' Research Fellow, Massachusetts General Hospital and Harvard Medical School. -
Management of the 'Young' Patient with Hip Disease
ARTHROPLASTY OF THE LOWER EXTREMITIES Management of the ‘Young’ Patient with Hip Disease SCOTT A. RITTERMAN, MD; LEE E. RUBIN, MD ABSTRACT abnormalities lead to impingement within the joint, altered Although hip arthritis typically affects older patients, biomechanics and ultimately cartilage loss.2 Secondary there is a rapidly growing population of “young” patients osteoarthritis can be due to an identifiable cause such as experiencing debilitating symptoms from hip disease. trauma to the femoral head, post-infection arthritis, slipped Most commonly, osteoarthritis and avascular necrosis af- capital femoral epiphysis, or hip dysplasia. fect this population, but a variety of other primary struc- As we age, the water content of cartilage increases with tural and metabolic causes can also occur. The expecta- a concomitant decrease in protein content, both leading to tions of these younger patients are often distinct from degeneration. The progressive loss of the cartilage matrix geriatric patients, and the challenges in optimizing their leads to recurrent bouts of inflammation as bone contacts care are unique in this demanding population. Selection bone, and reactive bone called osteophyte forms around the of the implant, bearing surface, and surgical technique joint. In the subchondral bone, hardening and cyst formation can all impact the success and longevity of total hip re- occurs. Repeated bouts of inflammation also extend into the placement. A consideration for respecting the native peri-articular soft tissues leading to deformity and contrac- bone stock is an important consideration that can poten- tures of the capsule, supporting ligaments, and tendons. Put tially reduce some of the future challenges of revision ar- together, these changes lead to pain, stiffness, and gait dis- throplasty in this young population. -
CKD: Bone Mineral Metabolism Peter Birks, Nephrology Fellow
CKD: Bone Mineral Metabolism Peter Birks, Nephrology Fellow CKD - KDIGO Definition and Classification of CKD ◦ CKD: abnormalities of kidney structure/function for > 3 months with health implications ≥1 marker of kidney damage: ACR ≥30 mg/g Urine sediment abnormalities Electrolyte and other abnormalities due to tubular disorders Abnormalities detected by histology Structural abnormalities (imaging) History of kidney transplant OR GFR < 60 Parathyroid glands 4 glands behind thyroid in front of neck Parathyroid physiology Parathyroid hormone Normal circumstances PTH: ◦ Increases calcium ◦ Lowers PO4 (the renal excretion outweighs the bone release and gut absorption) ◦ Increases Vitamin D Controlled by feedback ◦ Low Ca and high PO4 increase PTH ◦ High Ca and low PO4 decrease PTH In renal disease: Gets all messed up! Decreased phosphate clearance: High Po4 Low 1,25 OH vitamin D = Low Ca Phosphate binds calcium = Low Ca Low calcium, high phosphate, and low VitD all feedback to cause more PTH release This is referred to as secondary hyperparathyroidism Usually not seen until GFR < 45 Who cares Chronically high PTH ◦ High bone turnover = renal osteodystrophy Osteoporosis/fractures Osteomalacia Osteitis fibrosa cystica High phosphate ◦ Associated with faster progression CKD ◦ Associated with higher mortality Calcium-phosphate precipitation ◦ Soft tissue, blood vessels (eg: coronary arteries) Low 1,25 OH-VitD ◦ Immune status, cardiac health? KDIGO KDIGO: Kidney Disease Improving Global Outcomes Most recent update regarding -
Oncogenic Osteomalacia
ONCOGENIC_Martini 14/06/2006 10.27 Pagina 76 Case report Oncogenic osteomalacia Giuseppe Martini choice; if the tumour cannot be found or if the tumour is unre- Fabrizio Valleggi sectable for its location, chronic administration of phosphate Luigi Gennari and calcitriol is indicated. Daniela Merlotti KEY WORDS: oncogenic osteomalacia, hypophosphoremia, fractures, oc- Vincenzo De Paola treotide scintigraphy. Roberto Valenti Ranuccio Nuti Introduction Department of Internal Medicine, Endocrine-Metabolic Sciences and Biochemistry, University of Siena, Italy Osteomalacia is a metabolic bone disorder characterized by reduced mineralization and increase in osteoid thickness. Address for correspondence: This disorder typically occurs in adults, due to different condi- Prof. Giuseppe Martini tions impairing matrix mineralization. Its major symptoms are Dipartimento di Medicina Interna e Malattie Metaboliche diffuse bone pain, muscle weakness and bone fractures with Azienda Ospedaliera Senese minimal trauma. When occurs in children, it is associated with Policlinico “S. Maria alle Scotte” a failure or delay in the mineralization of endochondral new Viale Bracci 7, 53100 Siena, Italy bone formation at the growth plates, causing gait distur- Ph. 0577586452 bances, growth retardation, and skeletal deformities, and it is Fax 0577233446 called rickets. E-mail: [email protected] Histologically patients with osteomalacia present an abun- dance of unmineralized matrix, sometimes to the extent that whole trabeculae appeared to be composed of only osteoid -
Download (2MB)
extrait du symposium REIN ET CALCIUM les trois epis (haut-rhin) 14-17decembre 1972 A SANDOZ EDITIONS HYPERPARATHYROIDISM AFTER KIDNEY HOMOTRANSPLANTATION I. RELATION TO HOMOGRAFT FUNCTION M.M. POPOVTZER, W.P. GElS, T. E. STARZL Departments of Medicine and Surgery. Division of Renal Diseases. University of Colorado Medical Center and Veterans Administration Hospital. Denver. Colorado. U.S.A. INTRODUCTION Secondary hyperparathyroidism is present in most patients with chronic renal failure (11. 20. 21). The effect of renal transplan tation on parathyroid function has been generally studied over a relatively short period of time after surgery (1. 6). Thus the information which could be obtained was insufficient to provide evidence regarding the long-term variations in the parathyroid activity in renal homograft recipients. Acute .hypercalcemia immediately after kidney transplantation has been reported in detail by several investigators (12. 11. 19). Parathyroidectomy which was the treatment of choice resulted in a prompt reduction of the high serum calcium concentrations and a relief. of the attendant clinical manifestations in the reported cases (12. 11. 19). The pathogenesis of acute post-transplant hypercalcemia has not 145 been fully defined, yet several contributing factors could be implicated: (1) the presence of high levels of parathyroid hormone with restored to normal bone responsiveness to the hormone, (2) fall in serum concentration of phosphorus with a reciprocal rise in serum calcium, and (3) correction of the abnormal meta bolism of Vitamin 0 with an enhanced conversion of the vitamin to its active metabolites. Several workers postulated that resolution of secondary hyper parathyroidism after kidney transplantation occurs almost uni versally whereas hypercalcemia is unfrequent and if present it is usually associated with phosphate depletion and can be easily controlled with phosphate supplementation (1, 6, 7). -
1019 2 Feb 11 Weisbrode FINAL.Pages
The Armed Forces Institute of Pathology Department of Veterinary Pathology Wednesday Slide Conference 2010-2011 Conference 19 2 February 2011 Conference Moderator: Steven E. Weisbrode, DVM, PhD, Diplomate ACVP CASE I: 2173 (AFIP 2790938). Signalment: 3.5-month-old, male intact, Chow-Rottweiler cross, canine (Canis familiaris). History: This 3.5-month-old male Chow-Rottweiler mixed breed dog was presented to a veterinary clinic with severe neck pain. No cervical vertebral lesions were seen radiographically. The dog responded to symptomatic treatment. A week later the dog again presented with neck pain and sternal recumbency. The nose was swollen, and the submandibular and popliteal lymph nodes were moderately enlarged. The body temperature was normal. A complete blood count (CBC) revealed a marked lymphocytosis (23,800 lymphocytes/uI). Over a 3-4 hour period there was a noticeable increase in the size of all peripheral lymph nodes. Treatment included systemic antibiotics and corticosteroids. The dog became ataxic and developed partial paralysis. The neurologic signs waxed and waned over a period of 7 days, and the lymphadenopathy persisted. The peripheral blood lymphocyte count 5 days after the first CBC was done revealed a lymphocyte count of 6,000 lymphocytes/uI. The clinical signs became progressively worse, and the dog was euthanized two weeks after the initial presentation. Laboratory Results: Immunohistochemical (IHC) staining of bone marrow and lymph node sections revealed that tumor cells were negative for CD3 and CD79α. Gross Pathology: Marked generalized lymph node enlargement was found. Cut surfaces of the nodes bulged out and had a white homogeneous appearance. The spleen was enlarged and meaty. -
Musculoskeletal Radiology
MUSCULOSKELETAL RADIOLOGY Developed by The Education Committee of the American Society of Musculoskeletal Radiology 1997-1998 Charles S. Resnik, M.D. (Co-chair) Arthur A. De Smet, M.D. (Co-chair) Felix S. Chew, M.D., Ed.M. Mary Kathol, M.D. Mark Kransdorf, M.D., Lynne S. Steinbach, M.D. INTRODUCTION The following curriculum guide comprises a list of subjects which are important to a thorough understanding of disorders that affect the musculoskeletal system. It does not include every musculoskeletal condition, yet it is comprehensive enough to fulfill three basic requirements: 1.to provide practicing radiologists with the fundamentals needed to be valuable consultants to orthopedic surgeons, rheumatologists, and other referring physicians, 2.to provide radiology residency program directors with a guide to subjects that should be covered in a four year teaching curriculum, and 3.to serve as a “study guide” for diagnostic radiology residents. To that end, much of the material has been divided into “basic” and “advanced” categories. Basic material includes fundamental information that radiology residents should be able to learn, while advanced material includes information that musculoskeletal radiologists might expect to master. It is acknowledged that this division is somewhat arbitrary. It is the authors’ hope that each user of this guide will gain an appreciation for the information that is needed for the successful practice of musculoskeletal radiology. I. Aspects of Basic Science Related to Bone A. Histogenesis of developing bone 1. Intramembranous ossification 2. Endochondral ossification 3. Remodeling B. Bone anatomy 1. Cellular constituents a. Osteoblasts b. Osteoclasts 2. Non cellular constituents a.